MedTrace Logo

Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer

NCT02388074 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2015-07-14

Study results available
· View outcomes & findings →

Summary

This is a single center study to assess the efficacy of CyPath® Early Detection Lung Cancer Assay to detect lung cancer cells from deep lung sputum.

Conditions

Interventions

DEVICE

CyPath®

CyPath® diagnostic assay for the early detection of lung cancer using sputum

Sponsors & Collaborators

  • Radiology Associates of Albuquerque

    collaborator OTHER

  • bioAffinity Technologies Inc.

    lead INDUSTRY

Principal Investigators

  • Lara Patriquin, MD · Radiology Associates of Albuquerque

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02388074 on ClinicalTrials.gov